{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:04:24Z","timestamp":1776463464947,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-109-2320-B-016-011"],"award-info":[{"award-number":["MOST-109-2320-B-016-011"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111855","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T18:00:35Z","timestamp":1625335235000},"page":"111855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model"],"prefix":"10.1016","volume":"141","author":[{"given":"Shu-Hao","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Chun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Heng","family":"Pao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Huei","family":"Hsiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jaan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2021.111855_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI100206","article-title":"Studies of urea excretion. II: Relationship between urine volume and the rate of urea excretion by normal adults","volume":"6","author":"M\u00f6ller","year":"1928","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2021.111855_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejps.2018.08.011","article-title":"Discussions on the hepatic well-stirred model: re-derivation from the dispersion model and re-analysis of the lidocaine data","volume":"124","author":"Dong","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2021.111855_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ajcp\/18.10.789","article-title":"The concept of hepatic clearance","volume":"18","author":"Lewis","year":"1948","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111855_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jps.2600610111","article-title":"Influence of route of administration on drug availability","volume":"61","author":"Rowland","year":"1972","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111855_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01059626","article-title":"Clearance concepts in pharmacokinetics","volume":"1","author":"Rowland","year":"1973","journal-title":"J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.biopha.2021.111855_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance","volume":"5","author":"Pang","year":"1977","journal-title":"J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2021.111855_bib7","series-title":"The Liver. Quantitative Aspects of Structure and Function","first-page":"144","article-title":"Clearance as a Quantitative Measure of Liver Function","author":"Winkler","year":"1973"},{"issue":"5","key":"10.1016\/j.biopha.2021.111855_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jps.2600740522","article-title":"Hepatic elimination--dispersion model","volume":"74","author":"Roberts","year":"1985","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111855_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1023\/B:PHAM.0000026429.12114.7d","article-title":"Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes","volume":"21","author":"Ito","year":"2004","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111855_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cpt.802","article-title":"The universally unrecognized assumption in predicting drug clearance and organ extraction ratio","volume":"103","author":"Benet","year":"2018","journal-title":"Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2021.111855_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cpt.921","article-title":"Commentary on \u201cthe universally unrecognized assumption in predicting drug clearance and organ extraction ratio\u201d","volume":"103","author":"Rowland","year":"2018","journal-title":"Clin. Pharm. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.111855_bib12","article-title":"Hepatic clearance concepts and misconceptions: why the well-stirred model is still used even though it is not physiologic reality?","volume":"169","author":"Pang","year":"2019","journal-title":"Biochem. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2021.111855_bib13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/dmd.119.088872","article-title":"Protein binding and hepatic clearance: re-examining the discrimination between models of hepatic clearance with diazepam in the isolated perfused rat liver preparation","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.biopha.2021.111855_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12248-020-00501-9","article-title":"Investigating the theoretical basis for in vitro\u2013in vivo extrapolation (IVIVE) in predicting drug metabolic clearance and proposing future experimental pathways","volume":"22","author":"Benet","year":"2020","journal-title":"AAPS J."},{"issue":"11","key":"10.1016\/j.biopha.2021.111855_bib15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1124\/dmd.117.077040","article-title":"Clearance prediction methodology needs fundamental improvement: trends common to rat and human hepatocytes\/microsomes and implications for experimental methodology","volume":"45","author":"Wood","year":"2017","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2021.111855_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01059274","article-title":"Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation","volume":"12","author":"Rowland","year":"1984","journal-title":"J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2021.111855_bib17","series-title":"Drug Absorption, Distribution and Elimination, Principles and Practice of Pharmacology for Anaesthetists","first-page":"1","author":"Calvey","year":"2008"},{"issue":"8","key":"10.1016\/j.biopha.2021.111855_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/138920008786049258","article-title":"Benzodiazepine metabolism: an analytical perspective","volume":"9","author":"Mandrioli","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2021.111855_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neuropharm.2017.08.002","article-title":"Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology","volume":"128","author":"Gustafsson","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.biopha.2021.111855_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.2042-7158.1983.tb02961.x","article-title":"Protein binding and hepatic extraction of diazepam across the rat liver","volume":"35","author":"Rowland","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111855_bib21","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1002\/jps.21317","article-title":"Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding","volume":"97","author":"Waters","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111855_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01071000","article-title":"Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver","volume":"20","author":"Diaz-Garcia","year":"1992","journal-title":"J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.biopha.2021.111855_bib23","first-page":"279","article-title":"Cautionary Note about R2","volume":"39","author":"Kvalseth","year":"1985","journal-title":"Am. Stat."},{"issue":"4","key":"10.1016\/j.biopha.2021.111855_bib24","first-page":"138","article-title":"Intra- and extravascular distribution of albumin and immunoglobulin in man","volume":"11","author":"Rossing","year":"1978","journal-title":"Lymphology"},{"issue":"8","key":"10.1016\/j.biopha.2021.111855_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2044.1998.00438.x","article-title":"Serum albumin: touchstone or totem?","volume":"53","author":"Margarson","year":"1998","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111855_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10616-010-9263-3","article-title":"Albumin and mammalian cell culture: implications for biotechnology applications","volume":"62","author":"Francis","year":"2010","journal-title":"Cytotechnology"},{"issue":"7","key":"10.1016\/j.biopha.2021.111855_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.120.090530","article-title":"Are there any experimental perfusion data that preferentially support the dispersion and parallel-tube models over the well-stirred model of organ elimination?","volume":"48","author":"Sodhi","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.biopha.2021.111855_bib28","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s11095-010-0218-3","article-title":"Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view","volume":"27","author":"Hallifax","year":"2010","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.111855_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/00498254.2011.560294","article-title":"Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model","volume":"41","author":"Cubitt","year":"2011","journal-title":"Xenobiotica"},{"issue":"19","key":"10.1016\/j.biopha.2021.111855_bib30","doi-asserted-by":"crossref","first-page":"28612","DOI":"10.18632\/oncotarget.8704","article-title":"Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2021.111855_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejps.2018.08.008","article-title":"An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation","volume":"123","author":"Bowman","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111855_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-018-2551-x","article-title":"Pharmacokinetic and pharmacodynamic considerations for drugs binding to alpha-1-acid glycoprotein","volume":"36","author":"Smith","year":"2018","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.111855_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.119.087163","article-title":"Plasma protein binding as an optimizable parameter for acidic drugs","volume":"47","author":"Gardiner","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2021.111855_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"J. Parent. Enter. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2021.111855_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:25:43Z","timestamp":1776461143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221006375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S0753332221006375"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111855","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111855"}}